Indoco Remedies Ltd.
INDOCO Share PricePharmaceuticals & Drugs
₹252.25
-3.2 (-1.2%)
As on December 4, 2025
Exchange Scrips: BSE532612NSEINDOCOISININE873D01024
Market Cap ₹ 2,316 Cr
P/E Ratio -31.56
Dividend Yield 0.04 %
Performance
Market performance
Open255
High256.25
Volumes21,820
Prev252.25
Low251.6
As on2025-12-04
Historical performance
1 Year High349.8
3 Year High423.9
5 Year High530.25
1 Year Low190
3 Year Low190
5 Year Low190
Fundamentals
Company Valuation
Market Cap (₹Cr)
2,316
Face Value (₹)
2
P/E Ratio
-31.56
Dividend Yield
0.04 %
Investment Returns
1 Year
-21.8%
3 Years
-36.6%
5 Years
-17%
10 Years
-19.3%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 256.66 | Bearish |
| 10-DMA | 256.75 | Bearish |
| 20-DMA | 260.1 | Bearish |
| 50-DMA | 275.86 | Bearish |
| 100-DMA | 286.95 | Bearish |
| 200-DMA | 271.12 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 12 | 15 | 15 | 15 | 15 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 12 | 15 | 15 | 15 | 15 |
| Public Investors | 33307 | 33114 | 34482 | 34661 | 34401 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of -31.56.
- 3Y Stock Price CAGR of the stock is -13.7.
- The stock has a beta of 0.7.
- In the last financial year, the company had an EBITDA of ₹1047 Million.
- The company generated revenue of ₹16649 Million in the previous financial year.
Indoco Remedies Ltd.
252.25-3.2 (-1.2%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 785214
No. of Shares: 3113 (Approx)
Performance:-21.5%
P/L: ₹-214786
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
